Skip to main content
PM

Prolira makers of DeltaScan

DeltaScan Brain State Monitor is an EEG bedside device that provides objective brain health assessments in just five minutes, enabling timely interventions for patients at risk of acute encephalopathy and delirium. This technology addresses the high incidence of undetected delirium in surgical and ICU patients, which significantly impacts recovery and healthcare costs.

Utrecht, The NetherlandsFounded 201541K+ followers
Updated 20 months ago

Funding

$7.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Delirium and acute encephalopathy are common post-operative complications, particularly in older adults, and often go undetected in daily care. The failure to recognize these conditions can lead to delayed interventions and increased healthcare costs. Current methods for assessing brain health can be subjective and time-consuming.

Solution

DeltaScan Brain State Monitor is an EEG-based bedside device designed for the rapid and objective assessment of brain health, specifically to aid in the detection of acute encephalopathy and delirium. The device provides a quantitative measurement of brain function in approximately five minutes, enabling clinicians to make timely interventions, often before symptoms are readily apparent. By offering an objective measurement, DeltaScan aims to improve delirium management and facilitate prompt responses to neurotoxicity-generating treatments, ultimately improving patient outcomes and reducing healthcare expenditures associated with these complications. The device is both FDA-cleared and EU MDR certified.

Target Audience

The primary target audience includes healthcare providers in hospitals and intensive care units, particularly those focused on geriatric care and post-operative recovery.

Features

  • EEG-based technology for objective brain health assessment
  • Rapid 5-minute measurement time
  • Designed for bedside use in surgical and ICU settings
  • Aids in early detection of acute encephalopathy and delirium
  • Facilitates timely interventions and improved delirium management
  • Provides objective data to support clinical decision-making
This profile is AI-generated and may contain inaccuracies.